PERMISSIVE ROLE OF VASCULAR ENDOTHELIUM IN FIBROSIS.

endothelial-mesenchymal transition extracellular matrix mechanochemical coupling premature cell senescence vascular permeability

Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
15 Jan 2024
Historique:
medline: 15 1 2024
pubmed: 15 1 2024
entrez: 15 1 2024
Statut: aheadofprint

Résumé

Fibrosis, morphologic end-result of plethora of chronic conditions and the scorch for organ function, has been thoroughly investigated. One aspect of its development and progression, namely the permissive role of vascular endothelium, has been overshadowed by studies into (myo)fibroblasts and TGFβ; thus, it is the subject of the present review. It has been established that tensile forces of the extracellular matrix acting on cells are a prerequisite for mechanochemical coupling leading to liberation of TGFβ and formation of myofibroblasts. Increased tensile forces are prompted by elevated vascular permeability in response to diverse stressors resulting in exudation of fibronectin, fibrinogen/fibrin and other proteins, all stiffening the extracellular matrix. These processes lead to development of endothelial cells dysfunction, endothelial-to-mesenchymal transition, premature senescence of endothelial cells, perturbation of blood flow, and gradual obliteration of microvasculature leaving behind "string' vessels. The resulting microvascular rarefaction is not only a constant companion of fibrosis, but also an adjunct mechanism of its progression. The deepening knowledge of the above chain of pathogenetic events involving endothelial cells, namely increased permeability - stiffening of the matrix - endothelial dysfunction - microvascular rarefaction - tissue fibrosis, may provide a roadmap for therapeutic interventions deemed to curtail and reverse fibrosis.

Identifiants

pubmed: 38223932
doi: 10.1152/ajpcell.00526.2023
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Institute of Health USA
ID : HL144528

Auteurs

Michael S Goligorsky (MS)

Renal Research Institute and Departments of Medicine, Pharmacology and Physiology, New York Medical College at the Touro University, Valhalla, New York, United States.

Classifications MeSH